CARM1 and non-small cell lung carcinoma: These results are consistent with those obtained in the CARM1 knockdown experiments, indicating that the inhibition of CARM1 enzymatic activity results in the repression of CCNE2 expression in NSCLC cells and subsequently inhibits NSCLC progression.